MLSS Milestone Scientific Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: MLSS

Price (delayed)

$0.399

Market cap

$35.14M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.05

Enterprise value

$34.93M

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 65
Relative Valuation: Rel. Valuation: 14
Relative Profitability: Rel. Profitability: 25

Milestone Scientific Inc. (Milestone) is engaged in computer-controlled injection technologies and solutions for the medical and dental markets. Milestone has developed a computer-controlled anesthetic delivery instrument, through the use of ...

Highlights
Milestone Scientific's EPS has increased by 29% from the previous quarter and by 29% YoY
The net income has grown by 20% since the previous quarter and by 13% year-on-year
The equity has contracted by 49% YoY and by 19% from the previous quarter
The company's quick ratio fell by 42% YoY and by 18% QoQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.milestonescientific.com
Peers: APT XRAY ALGN

Key stats

What are the main financial stats of MLSS

MLSS stock price

How has the Milestone Scientific stock price performed over time
Intraday
2.02%
1 week
2.26%
1 month
24.3%
1 year
-17.07%
YTD
46.15%
QTD
24.3%

Financial performance

How have Milestone Scientific's revenue and profit performed over time
Revenue
$8.9M
Gross profit
$6.32M
Operating income
-$4.53M
Net income
-$4.57M
Gross margin
71%
Net margin
-51.3%
The operating margin has increased by 40% year-on-year and by 20% since the previous quarter
MLSS's operating income is up by 38% year-on-year and by 21% since the previous quarter
The net margin has grown by 20% from the previous quarter and by 16% YoY
The net income has grown by 20% since the previous quarter and by 13% year-on-year

Price vs fundamentals

How does MLSS's price correlate with its fundamentals

Growth

What is Milestone Scientific's growth rate over time

Valuation

What is Milestone Scientific stock price valuation
P/E
N/A
P/B
14.05
P/S
3.81
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.92
Milestone Scientific's EPS has increased by 29% from the previous quarter and by 29% YoY
The P/B is 63% higher than the 5-year quarterly average of 8.6 and 20% higher than the last 4 quarters average of 11.7
The equity has contracted by 49% YoY and by 19% from the previous quarter
The P/S is 46% less than the 5-year quarterly average of 7.0
The revenue is up by 3.4% year-on-year

Efficiency

How efficient is Milestone Scientific business performance
The return on equity has dropped by 101% year-on-year but it has increased by 4.4% since the previous quarter
The company's return on invested capital rose by 30% YoY and by 22% QoQ
Milestone Scientific's ROS has increased by 20% from the previous quarter and by 17% YoY
MLSS's ROA is up by 17% QoQ but it is down by 13% YoY

Dividends

What is MLSS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MLSS.

Financial health

How did Milestone Scientific financials performed over time
The total assets is 40% greater than the total liabilities
The company's quick ratio fell by 42% YoY and by 18% QoQ
The total liabilities has increased by 23% year-on-year and by 14% since the previous quarter
The debt is 57% less than the equity
The equity has contracted by 49% YoY and by 19% from the previous quarter
Milestone Scientific's debt to equity has increased by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.